Epidemiology of congenital hypothyroidism in Markazi Province, Iran

Fatemeh Dorreh1, Parsa Y Chaijan, Javad Javaheri

  • 1abriz University of Medical Sciences, National Public Health Management Center, Department of Community Medicine, Tabriz, Iran. E-ma-il: zenalali@gmail.com.

Insights

Congenital hypothyroidism (CH) affects 1 in 307 newborns in Markazi Province, Iran, a higher prevalence than global averages. Further research is needed to identify risk factors for this condition.

Area of Science:

  • Endocrinology
  • Pediatrics
  • Public Health

Background:

  • Congenital hypothyroidism (CH) is a common endocrine disorder in newborns.
  • Early detection and management of CH are crucial to prevent intellectual disability and developmental delays.
  • Epidemiological data on CH prevalence in specific regions like Markazi Province, Iran, are essential for targeted public health interventions.

Purpose of the Study:

  • To investigate the epidemiology of congenital hypothyroidism (CH) in newborns in Markazi Province, Iran.
  • To determine the prevalence and characteristics of CH in the studied population.
  • To provide baseline data for future research and public health strategies.

Main Methods:

  • A cross-sectional study was conducted from 2006 to 2012, screening 127,112 newborns.
  • Heel-prick blood samples were collected 3-5 days after birth.
  • Thyroid-stimulating hormone (TSH) levels were measured using enzyme-linked immunosorbent assay (ELISA); TSH >5 mIU/L prompted re-examination.

Main Results:

  • The overall prevalence of CH was 1:307, with a female to male ratio of 1:0.95.
  • The prevalence of permanent CH was 1:581, and transient CH was 1:628.
  • A total of 414 CH cases were detected among 6102 recalled infants, indicating a 4.8% re-call rate.

Conclusions:

  • The prevalence of CH in Markazi Province is significantly higher than global estimates.
  • Comprehensive studies to identify risk factors associated with CH in this region are urgently needed.
  • These findings highlight the importance of continued newborn screening programs and further research for effective health system planning.
Abstract

Related Concept Videos

Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
20
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
28
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH...
26
Goiter01:27

Goiter

Goiter refers to an abnormal enlargement of the thyroid gland that may appear as a diffuse goiter (uniform enlargement) or nodular (single or multiple nodules). Functionally, it is classified as nontoxic (normal/low hormone levels) or toxic (excess hormone production).PathophysiologyDiffuse thyroid enlargement typically results from prolonged stimulation by thyroid-stimulating hormone (TSH) or TSH-like agents, commonly seen in hypothyroidism or iodine deficiency. In contrast, in hyperthyroid...
29
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence...
19
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
7.1K